Perceptive Advisors’s Enzo Biochem ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-83,893
Closed -$582K – 204
2016
Q4
$582K Buy
83,893
+16,780
+25% +$107K 0.04% 108
2016
Q3
$342K Hold
67,113
– – 0.02% 147
2016
Q2
$401K Buy
+67,113
New +$372K 0.03% 133
2014
Q2
– Sell
-380,000
Closed -$1.58M – 144
2014
Q1
$1.58M Buy
+380,000
New +$1.3M 0.17% 81

Other funds holding ENZ

Perceptive Advisors's ENZ Position: Q1 2017 in Review

Perceptive Advisors sold out of Enzo Biochem (ENZ) in Q1 2017, closing a stake of 83,893 shares — an estimated $582K sold.

Perceptive Advisors first reported a position in ENZ in Q1 2014 and held it in 4 quarters. The position peaked at $1.58M in Q1 2014. 109 funds tracked by Wall St. Rank hold ENZ as of Q1 2017.

  • Perceptive Advisors reported no remaining Enzo Biochem position as of Q1 2017 after selling out during the quarter.
  • Perceptive Advisors sold 83,893 Enzo Biochem shares in Q1 2017, an estimated $582K.
  • Perceptive Advisors first reported a position in Enzo Biochem in Q1 2014 and held it in 4 quarters.
  • Perceptive Advisors's Enzo Biochem position peaked at $1.58M in Q1 2014.
  • 109 funds tracked by Wall St. Rank held Enzo Biochem as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.